Apr 3 |
Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
|
Mar 22 |
Alvotech Announces Increase in Number of Own Shares
|
Mar 22 |
Analysts Expect Breakeven For Alvotech (NASDAQ:ALVO) Before Long
|
Mar 21 |
Alvotech (ALVO) Q4 2023 Earnings Call Transcript
|
Mar 20 |
Alvotech GAAP EPS of -$2.43, revenue of $93.4M
|
Mar 20 |
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
|
Mar 20 |
Earnings Scheduled For March 20, 2024
|
Mar 5 |
Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
|
Feb 29 |
Alvotech Appoints Interim Chief Quality Officer
|
Feb 26 |
Alvotech/Teva win FDA approval for Humira biosimilar
|